Megluminantimonate
DefinitionThis section has been translated automatically.
IndicationThis section has been translated automatically.
Dosage and method of useThis section has been translated automatically.
Remember! Maximum dose 850 mg/day!
- Visceral Leishmaniasis: 20 mg/kg bw/day for at least 20 days (until no more parasites can be detected).
- Cutaneous leishmaniasis (except L. aethiopica, brasiliensis, guyanamensis):
- Local therapy: Injection of 1-3 ml under the ulcer, possibly 1-2 scds at intervals of 1-2 days.
- Systemic: 10-20 mg/kg bw/day until the smears are negative and then another 3 days.
- Cutaneous leishmaniasis (L. brasiliensis): 20 mg/kg bw/day until the lesion is healed (max. 4 weeks).
- Mucocutaneous leishmaniasis: 20 mg/kg bw/day until the smear is negative (max. 4 weeks).
- Diffuse cutaneous leishmaniasis: 20 mg/kg bw/day until clinical improvement occurs (usually for months).
PreparationsThis section has been translated automatically.
Glucantime (available through the international pharmacy).